DK0830608T3 - Thromboseriskotest - Google Patents
ThromboseriskotestInfo
- Publication number
- DK0830608T3 DK0830608T3 DK96919107T DK96919107T DK0830608T3 DK 0830608 T3 DK0830608 T3 DK 0830608T3 DK 96919107 T DK96919107 T DK 96919107T DK 96919107 T DK96919107 T DK 96919107T DK 0830608 T3 DK0830608 T3 DK 0830608T3
- Authority
- DK
- Denmark
- Prior art keywords
- reagent
- protein
- plasma
- subject
- sample
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
- G01N2333/4613—Snake venom
- G01N2333/462—Snake venom from Agkistrodon sp., e.g. acutase, ACTE
- G01N2333/4626—Snake venom from Agkistrodon sp., e.g. acutase, ACTE from Agkistrodon contortrix contortrix (copperhead snake); Protac (R)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96461—Protein C (3.4.21.69)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96463—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/04—Phospholipids, i.e. phosphoglycerides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Control Of Eletrric Generators (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/488,510 US5780255A (en) | 1995-06-09 | 1995-06-09 | Protein C pathway screening test |
PCT/US1996/009036 WO1996042018A1 (en) | 1995-06-09 | 1996-06-06 | Thrombosis risk test |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0830608T3 true DK0830608T3 (da) | 2000-11-20 |
Family
ID=23939946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96919107T DK0830608T3 (da) | 1995-06-09 | 1996-06-06 | Thromboseriskotest |
Country Status (9)
Country | Link |
---|---|
US (1) | US5780255A (da) |
EP (1) | EP0830608B1 (da) |
JP (1) | JP3248621B2 (da) |
AT (1) | ATE196804T1 (da) |
CA (1) | CA2224465A1 (da) |
DE (1) | DE69610558T2 (da) |
DK (1) | DK0830608T3 (da) |
ES (1) | ES2152531T3 (da) |
WO (1) | WO1996042018A1 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT72191A (en) * | 1993-01-29 | 1996-03-28 | Dahlbaeck | Novel anticoagulant cofactor activity |
US5708591A (en) * | 1995-02-14 | 1998-01-13 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
US6321164B1 (en) | 1995-06-07 | 2001-11-20 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade |
US6898532B1 (en) | 1995-06-07 | 2005-05-24 | Biomerieux, Inc. | Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample |
US6429017B1 (en) | 1999-02-04 | 2002-08-06 | Biomerieux | Method for predicting the presence of haemostatic dysfunction in a patient sample |
US6379975B1 (en) | 1996-11-27 | 2002-04-30 | T.A.C. Thrombosis And Coagulation Aktiebolag | Methods and reagents for determining protein S |
DE19724239A1 (de) * | 1997-06-09 | 1998-12-10 | Max Planck Gesellschaft | Dysprothrombinämie |
US6502040B2 (en) | 1997-12-31 | 2002-12-31 | Biomerieux, Inc. | Method for presenting thrombosis and hemostasis assay data |
AUPP159698A0 (en) * | 1998-02-02 | 1998-02-26 | Life Therapeutics Limited | Improved blood coagulation test |
DE19858278A1 (de) * | 1998-12-17 | 2000-06-21 | Dade Behring Marburg Gmbh | Verfahren zum Lokalisieren von Defekten im Gerinnungssystem |
ES2231167T3 (es) | 1999-02-04 | 2005-05-16 | Biomerieux, Inc. | Procedimiento y aparato para predecir la disfuncion hemostatica en una muestra de un paciente. |
EP1045250A1 (en) * | 1999-04-12 | 2000-10-18 | INSTRUMENTATION LABORATORY S.p.A. | A global test for evaluating the functionality of the thrombin/antithrombin system |
US20020037528A1 (en) * | 1999-08-13 | 2002-03-28 | Berg David E. | Method for detecting procoagulant genetic and metabolic conditions associated with, and potentially predispositional for, activation of the coagulation response |
US7179612B2 (en) | 2000-06-09 | 2007-02-20 | Biomerieux, Inc. | Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality |
US6432658B1 (en) | 2000-09-13 | 2002-08-13 | Affinity Biologicals, Inc. | Method for measuring antithrombin activity |
US20020165149A1 (en) * | 2000-12-08 | 2002-11-07 | Kranz David M. | Mutated class II major histocompatibility proteins |
JP2004528534A (ja) * | 2000-12-19 | 2004-09-16 | インスツルメンテーション ラボラトリー カンパニー | プロテインs機能的アッセイ |
US6855509B2 (en) * | 2000-12-19 | 2005-02-15 | Instrumentation Laboratory Company | Protein S functional assay and kit therefor |
RU2722280C1 (ru) * | 2019-09-27 | 2020-05-28 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) | Способ прогнозирования тромбоэмболических осложнений у женщин при носительстве мутаций гена протромбина [F2(20210)GA] |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2431342C3 (de) * | 1973-07-27 | 1978-10-26 | Behringwerke Ag, 3550 Marburg | Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe |
ES431736A1 (es) * | 1973-11-13 | 1977-05-16 | Behringwerke Ag | Procedimiento para la preparacion de un agente para diagnos-tico para el proposito de efectuar el control de la capaci- dad de coagulacion de la sangre. |
NL7508671A (nl) * | 1974-07-26 | 1976-01-28 | Behringwerke Ag | Werkwijze voor het bepalen van plastiminogeen. |
DE2461969A1 (de) * | 1974-12-31 | 1976-07-08 | Behringwerke Ag | Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen |
DE2601372C3 (de) * | 1976-01-15 | 1980-03-27 | Behringwerke Ag, 3550 Marburg | Verfahren zur Bestimmung von Antithrombin III |
DE2757992A1 (de) * | 1977-12-24 | 1979-06-28 | Boehringer Mannheim Gmbh | Verfahren zur prothrombin-bestimmung |
JPS5856695A (ja) * | 1981-09-28 | 1983-04-04 | Nitto Boseki Co Ltd | 新規なトロンビン測定用基質 |
CA1213198A (en) * | 1982-09-29 | 1986-10-28 | James E. Hughes | Diagnostic activated partial thromboplastin reagent |
DE3311287A1 (de) * | 1983-03-28 | 1984-10-04 | Behringwerke Ag, 3550 Marburg | Verfahren zur fotometrischen bestimmung der aktivierten partiellen thromboplastinzeit und reagenz dazu |
DE3330699A1 (de) * | 1983-08-25 | 1985-03-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur gleichzeitigen bestimmung von fibrinogen und fibrinogen-spaltprodukten im plasma |
DE3400434A1 (de) * | 1984-01-09 | 1985-09-26 | Behringwerke Ag, 3550 Marburg | Bestimmung von fibrin mit fibrin-spezifischen antikoerpern |
DE3413311A1 (de) * | 1984-04-09 | 1985-10-17 | Behringwerke Ag, 3550 Marburg | Reagenz zur bestimmung der thromboplastinzeit |
US4849403A (en) * | 1985-05-29 | 1989-07-18 | Pentapharm Ag | Protein C activator, methods of preparation and use thereof |
DE3607559A1 (de) * | 1986-03-07 | 1987-09-10 | Boehringer Mannheim Gmbh | Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet |
US5200322A (en) * | 1986-09-19 | 1993-04-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for assaying protein C and measuring kit for the same |
DE3736589A1 (de) * | 1987-10-29 | 1989-05-11 | Behringwerke Ag | Glutaminhaltige peptide, verfahren zu deren herstellung und verwendung |
DE3811647A1 (de) * | 1988-04-07 | 1989-10-26 | Behringwerke Ag | Verfahren und verpackung enthaltend mittel zur kinetischen bestimmung von faktor xiii |
US5206140A (en) * | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
IT1230744B (it) * | 1989-07-07 | 1991-10-29 | Instrumentation Lab Spa | Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano. |
SE464135B (sv) * | 1989-07-14 | 1991-03-11 | Kabivitrum Ab | Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov |
US5169786A (en) * | 1989-12-19 | 1992-12-08 | Ortho Diagnostic Systems, Inc. | Method of determining levels of extrinsic and intrinsic clotting factors and protein c |
DE4006634A1 (de) * | 1990-03-03 | 1991-09-05 | Behringwerke Ag | Funktioneller test zur bestimmung der protein s-aktivitaet |
WO1993007491A1 (en) * | 1991-10-04 | 1993-04-15 | Board Of Regents Of The University Of Nebraska | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
DE4133946A1 (de) * | 1991-10-14 | 1993-04-15 | Behringwerke Ag | Funktioneller test und reagenz zur bestimmung von fibrinogen |
EP0608235B2 (en) * | 1991-11-13 | 2005-05-04 | T.A.C. Thrombosis and Coagulation Aktiebolag | Method for the diagnosis of blood coagulation disorders |
FR2689640B1 (fr) * | 1992-04-06 | 1997-08-08 | Bio Merieux | Procede pour la determination d'une activite proteine c et/ou proteine s dans un echantillon plasmatique. |
EP0633473B1 (de) * | 1993-06-30 | 1999-03-10 | Stiftung Für Diagnostische Forschung | Messung des aktivierten partiellen Thromboplastinzeit (APTT) in einer Einstufen-Reaktion |
DE4427785A1 (de) * | 1994-08-08 | 1996-02-15 | Behringwerke Ag | Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems |
ES2154703T5 (es) * | 1994-11-10 | 2008-02-01 | Dade Behring Marburg Gmbh | Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada. |
-
1995
- 1995-06-09 US US08/488,510 patent/US5780255A/en not_active Expired - Fee Related
-
1996
- 1996-06-06 JP JP50314997A patent/JP3248621B2/ja not_active Expired - Fee Related
- 1996-06-06 WO PCT/US1996/009036 patent/WO1996042018A1/en not_active Application Discontinuation
- 1996-06-06 AT AT96919107T patent/ATE196804T1/de active
- 1996-06-06 ES ES96919107T patent/ES2152531T3/es not_active Expired - Lifetime
- 1996-06-06 DE DE69610558T patent/DE69610558T2/de not_active Revoked
- 1996-06-06 DK DK96919107T patent/DK0830608T3/da active
- 1996-06-06 EP EP96919107A patent/EP0830608B1/en not_active Revoked
- 1996-06-06 CA CA002224465A patent/CA2224465A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE196804T1 (de) | 2000-10-15 |
US5780255A (en) | 1998-07-14 |
WO1996042018A1 (en) | 1996-12-27 |
ES2152531T3 (es) | 2001-02-01 |
DE69610558D1 (en) | 2000-11-09 |
DE69610558T2 (de) | 2001-05-31 |
EP0830608A1 (en) | 1998-03-25 |
JP3248621B2 (ja) | 2002-01-21 |
MX9709961A (es) | 1998-10-31 |
CA2224465A1 (en) | 1996-12-27 |
JPH11504718A (ja) | 1999-04-27 |
EP0830608B1 (en) | 2000-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0830608T3 (da) | Thromboseriskotest | |
US20090087870A1 (en) | Hematological assay and kit | |
ATE315233T1 (de) | Verfahren zur bestimmung des antikoagulatorischen potentials einer probe und verfahren zur bestimmung der glykosilierung von thrombomodulin | |
ES547898A0 (es) | Un metodo para determinar la presencia de un componente de coagulacion | |
ATE121139T1 (de) | Verfahren zur bestimmung der konzentration von antikoagulantien. | |
AU694931B2 (en) | A method for detecting disturbances of the protein C/protein S system | |
JPS62212569A (ja) | タンパク質c―またはタンパク質s―活性を測光により測定する方法 | |
JPH0365958B2 (da) | ||
US5093237A (en) | Method and reagent for determining the biological activity of antithrombin iii by measuring coagulation time | |
US5308756A (en) | Protein S chromogenic assay | |
US5221614A (en) | Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time | |
US7727736B2 (en) | Soluble phospholipids for use in clotting factor assays | |
D'Angelo et al. | Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S | |
JPH04350560A (ja) | プロテインs活性の機能的測定方法 | |
Kirchhof et al. | Control of anticoagulant therapy with a chromogenic substrate | |
Wolf et al. | Clinical applications of a direct assay of free protein S antigen using monoclonal antibodies. A study of 59 cases | |
D’Angelo et al. | Monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for the measurement of vitamin K-dependent protein S: the effect of antibody immunoreactivity on plasma protein S antigen determinations | |
HU219457B (hu) | Meizotrombint, meizotrombin(des F1)-t vagy keverékeiket tartalmazó reagens, valamint tesztkészlet diagnosztikai célokra | |
Tripodi et al. | A chromogenic assay of prothrombin compared with coagulation tests during anticoagulant therapy and liver disease | |
Gaffney et al. | Monoclonal antibodies against fibrinogen, fibrin and their fragments | |
van den Besselaar et al. | The relationship between the international normalized ratio and the coumarin-induced coagulation defect | |
ROSE et al. | A comparison of antithrombin III procedures | |
Francis | A new chromogenic assay for the specific determination of prothrombin. | |
DE3724443A1 (de) | Funktioneller test zur bestimmung der protein s-aktivitaet | |
Graves-Hoagland et al. | Protein S and thrombosis |